Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

472
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
472
Behavior Therapy01:22

Behavior Therapy

752
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
752
Drug Therapy01:28

Drug Therapy

310
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
310
Cognitive Therapy01:25

Cognitive Therapy

1.3K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.3K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co- and Multi-Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Five-Year Follow-Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?

Movement disorders clinical practice·2026
Same author

The Journal at Forty: A Proud Legacy and a Look to the Future.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

A generalized framework for <i>in vivo</i> detection of dopamine release using positron emission tomography.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2025
Same author

Brain Bleeding Associated With Cavitation During Focused Ultrasound Ablation.

Neurosurgery·2025

Related Experiment Video

Updated: Feb 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K

Dyskinesias and levodopa therapy: why wait?

Michele Matarazzo1, Alexandra Perez-Soriano2, A Jon Stoessl2

  • 1Pacific Parkinson's Research Centre and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2221 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada. michele.matarazzo@gmail.com.

Journal of Neural Transmission (Vienna, Austria : 1996)
|February 12, 2018
PubMed
Summary
This summary is machine-generated.

For Parkinson's disease, levodopa therapy is recommended early, not delayed, to manage symptoms effectively. While dyskinesias are a concern, delaying levodopa doesn't prevent them and may worsen outcomes.

Keywords:
DyskinesiaLevodopa-induced dyskinesiaParkinson’s diseaseParkinson’s therapy

More Related Videos

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

5.2K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Na&#239;ve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.6K

Related Experiment Videos

Last Updated: Feb 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K
High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

5.2K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Na&#239;ve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.6K

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • The optimal timing for initiating levodopa therapy in Parkinson's disease (PD) remains a subject of debate.
  • Concerns exist regarding early levodopa use, particularly the risk of developing dyskinesias, especially in younger patients.

Purpose of the Study:

  • To review the historical perspective and current literature on levodopa therapy initiation in Parkinson's disease.
  • To identify intrinsic and modifiable risk factors associated with levodopa-induced dyskinesias.
  • To provide evidence-based recommendations for individualized treatment strategies in PD.

Main Methods:

  • Literature review of studies investigating levodopa therapy timing and motor complications in Parkinson's disease.
  • Analysis of factors contributing to levodopa-induced dyskinesias.
  • Historical narrative of treatment approaches for Parkinson's disease.

Main Results:

  • Current evidence suggests that delaying levodopa therapy does not significantly prevent or delay the onset of dyskinesias once levodopa is eventually introduced.
  • Levodopa offers superior symptomatic control for Parkinson's disease compared to alternative early treatments like dopamine agonists.
  • Alternative medications may have their own significant side effects, and levodopa-sparing strategies lack sufficient evidence.

Conclusions:

  • There is insufficient evidence to support levodopa-sparing strategies in early Parkinson's disease.
  • Individualized patient assessment, considering motor/non-motor needs and risk factors, is crucial for optimizing levodopa treatment.
  • Early initiation of levodopa, when indicated, should be considered for better symptom management in Parkinson's disease.